Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03950401 · ClinicalTrials.gov registry record · NA

Prospective Randomized Trial of Monocryl Versus Nylon Suture Closure in Carpal Tunnel Surgery

A NA study of Carpal Tunnel Syndrome, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
124
Enrollment target
1
Study location

NCT03950401 is a NA study of Carpal Tunnel Syndrome that has completed, run by University of California, Davis. The registered enrollment target is 124 participants, below the 217-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03950401, a NA study of Carpal Tunnel Syndrome, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

The investigators will compare the early postoperative outcome of wound closure technique in carpal tunnel release using Nylon sutures versus subcuticular Monocryl sutures. The investigators plan to randomize patients across three hand surgeons who will perform both techniques, and will survey the patients satisfaction of pain and appearance at 2 and 6 weeks postoperatively.

Conditions Studied

Interventions

  • PROCEDURE Monocryl
  • PROCEDURE Nylon

Study Locations (1)

California

  • University of California, Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2019-05-16
Est. Completion 2021-09-27
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03950401

The ClinicalTrials.gov registry entry for NCT03950401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 217-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (43% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Monocryl is the first listed.

NCT03950401 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03950401 about?

NCT03950401 is a clinical study titled "Prospective Randomized Trial of Monocryl Versus Nylon Suture Closure in Carpal Tunnel Surgery". The investigators will compare the early postoperative outcome of wound closure technique in carpal tunnel release using Nylon sutures versus subcuticular Monocryl sutures. The investigators plan to randomize patients across three hand surgeons who will perform both techniques, and will survey the p...

What is the current status of trial NCT03950401?

This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2019-05-16. Estimated completion is 2021-09-27.

What conditions does trial NCT03950401 study?

This clinical trial studies the following conditions: Carpal Tunnel Syndrome.

What interventions are being tested in trial NCT03950401?

The interventions under investigation include: Monocryl (PROCEDURE), Nylon (PROCEDURE).

Who is sponsoring clinical trial NCT03950401?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03950401 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carpal Tunnel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.